In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are used in the collection, preparation, and examination of specimens taken from the human body. This includes Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers, Oncology and Reproductive Health Diagnostics. Lyme Disease Tests are carried out to diagnose infections caused by the tick-borne bacterium Borrelia, which can result in neurological and joint disease. GlobalData uses proprietary data and analytics to provide a comprehensive report on the lyme disease tests devices market, including market shares of different players within Denmark. Buy the latest report here.
In 2023, GlobalData’s Market Model methodology determined that the leading player in the lyme disease tests market in Denmark was Revvity followed by Thermo Fisher Scientific, Bio-Rad Laboratories, bioMerieux, SD Biosensor, Sebia, Quidelortho and Trinity Biotech.
Lyme Disease include Lyme Disease Enzyme Immunoassay Tests, Lyme Disease Western Blot Tests, and Lyme Disease Other Tests which includes PCR testing.
The value of the lyme disease tests devices market within Denmark was expected to be over $0.06m in 2023.
For the latest complete market share analysis of lyme disease tests device market in Denmark, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.